Product Recalls: July 15, 2026 – August 19, 2026
Health Letter, September 2026
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS I
cetirizine hydrochloride tablets, 5 mg, 100-count bottle. Manufactured by: Unique Pharmaceuticals Labs (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.). Lot #: GY825029, GY825030, GY825031 or GY825032, exp. date: 2028-OCT.
CLASS II
amlodipine and olmesartan medoxomil tablets, 10 mg/20 mg, 30 tablets per bottle. Manufactured by: Alkem Laboratories Ltd. Lot #: 25121311, exp. date: 3/31/2028.
dicyclomine hydrochloride capsules, 10 mg, 1,000 bottles. Distributed by: Aurobindo Pharma USA, Inc. Batch #: DMC125018A, exp date: 07/2027.
Diovan (valsartan) tablets, 160 mg, 90 tablets. Manufactured by: Patheon Manufacturing Services LLC. Lot #: AV5913C, exp. date: 6/2027.
divalproex sodium delayed-release tablets, 500 mg, 500-tablet bottles. Distributed by: Bionpharma Inc. Lot #: 704C003, exp. date: 12/31/2028.
levothyroxine sodium tablets; 25, 50, 75, 88, 112, 125 or 150 mcg; 10 or 100 tablets (10 x 10 or 10 x 1 unit dose blisters) per carton. Packaged and Distributed by: MAJOR PHARMACEUTICALS. Lot #: N02212, exp. date: 07/2026; Lot #: N02200, exp. date: 10/2026; Lot #: N02172, exp. date: 07/2026; Lot #: N02296 or N02288, exp. date: 12/2026; Lot #: N02310, exp. date: 01/2027; Lot #: N02203, exp. date: 09/2026; Lot #: N02266, exp. date: 11/2026; Lot #: N02167, exp. date: 07/2026; Lot #: N02212A or N02212B, exp. date: 07/2026; Lot #: N02212, exp. date: 07/2026; Lot #: N02200A or N02200B, exp. date: 10/2026; Lot #: N02200, exp. date: 10/2026; Lot #: N02172A or N02172B, exp. date: 07/2026; Lot #: N02288A or N02288B, exp. date: 12/2026; Lot #: N02172, exp. date: 07/2026; Lot #: N02288, exp. date: 12/2026; Lot #: N02266A or N02266B, exp. date: 11/2026; Lot #: N02266, exp. date: 11/2026; Lot #: N02167A, exp. date: 07/2026; Lot #: N02167, exp. date: 07/2026.
mirabegron extended-release tablets, 25 mg, 30-count bottle. Manufactured by: Zydus Lifesciences Ltd. Lot #: E408618, exp. date: 11/30/2026.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.